A B Gottlieb Selected Research

A B Gottlieb Research Topics

Disease

42	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 05/2000
10	Necrosis 12/2021 - 06/2001
6	Psoriatic Arthritis 12/2021 - 01/2003
3	Infections 10/2015 - 06/2005
2	Herpes Zoster 01/2019 - 10/2015
2	Inflammation (Inflammations) 10/2015 - 02/2013
2	Autoimmune Diseases (Autoimmune Disease) 09/2015 - 09/2000
2	Fatigue 05/2008 - 12/2007
1	Hidradenitis Suppurativa 01/2019
1	Pruritus (Itching) 12/2015
1	Hyperplasia 10/2015
1	Stroke (Strokes) 10/2015
1	Infectious Arthritis (Septic Arthritis) 10/2015
1	Epiglottitis 10/2015
1	Melanoma (Melanoma, Malignant) 10/2015
1	Disease Progression 09/2015
1	Vitiligo 09/2015
1	Skin Diseases (Skin Disease) 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2013
1	Neoplasms (Cancer) 10/2013
1	Dizziness (Lightheadedness) 05/2008
1	Hepatitis C 12/2003
1	Ankylosing Spondylitis 12/2003
1	Rheumatoid Arthritis 12/2003
1	Immune System Diseases (Immune Disorders) 01/2003
1	Scalp Dermatoses 07/2001
1	Acne Vulgaris 11/2000
1	Chronic Disease (Chronic Diseases) 10/2000
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2000

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 01/2019 - 05/2000
8	Etanercept (Enbrel)FDA Link 12/2021 - 01/2003
6	Certolizumab Pegol FDA Link 01/2021 - 07/2012
6	Prostaglandins AIBA 03/2019 - 06/2001
6	Infliximab (Remicade)FDA Link 09/2015 - 05/2000
5	secukinumabIBA 12/2021 - 12/2014
4	Interleukin-12 (IL 12)IBA 12/2021 - 09/2011
4	Biological ProductsIBA 12/2021 - 05/2008
3	Adalimumab (Humira)FDA Link 12/2021 - 04/2015
3	Interleukin-17 (Interleukin 17)IBA 12/2021 - 08/2016
3	ixekizumabIBA 10/2018 - 03/2017
3	brodalumabIBA 08/2018 - 08/2016
3	CytokinesIBA 08/2016 - 09/2015
3	Pharmaceutical PreparationsIBA 10/2015 - 01/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003 - 05/2000
2	Ustekinumab (CNTO 1275)FDA Link 12/2021 - 01/2018
2	InterleukinsIBA 12/2021 - 10/2015
2	Biological FactorsIBA 01/2021 - 01/2021
2	tofacitinibIBA 01/2019 - 10/2015
2	Janus Kinase InhibitorsIBA 01/2019 - 10/2015
2	Antirheumatic Agents (DMARD)IBA 12/2018 - 12/2018
2	apremilastIBA 12/2015 - 05/2008
2	Immunoglobulin G (IgG)IBA 10/2015 - 05/2008
2	Immunoglobulin A (IgA)IBA 02/2015 - 12/2014
2	briakinumabIBA 10/2013 - 09/2011
2	Alefacept (Amevive)FDA Link 11/2005 - 01/2003
2	RetinoidsIBA 10/2001 - 11/2000
1	Interleukin-17 ReceptorsIBA 08/2018
1	Phosphodiesterase 4 InhibitorsIBA 12/2015
1	Interleukin-23 Subunit p19IBA 10/2015
1	ruxolitinibIBA 10/2015
1	Keratin-16 (Keratin 16)IBA 10/2015
1	tildrakizumabIBA 10/2015
1	Tumor Necrosis Factor InhibitorsIBA 09/2015
1	omega-Chloroacetophenone (Mace)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	NF-kappa B (NF-kB)IBA 02/2013
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 05/2008
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2008
1	Ointments (Pastes)IBA 05/2008
1	efalizumab (Raptiva)FDA Link 05/2008
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2008
1	pimecrolimus (Elidel)FDA Link 06/2005
1	Calcineurin InhibitorsIBA 06/2005
1	Ficusin (Psoralen)IBA 10/2001
1	Immunologic Factors (Immunomodulators)IBA 10/2001
1	Acitretin FDA Link 10/2001
1	Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric 07/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2001
1	Vitamin E FDA LinkGeneric 11/2000
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2000
1	OKT4A monoclonal antibodyIBA 10/2000
1	Interleukin-2 (IL2)IBA 09/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2000
1	Daclizumab (Zenapax)FDA Link 09/2000

Therapy/Procedure

13	Therapeutics 01/2019 - 05/2000
3	Biological Therapy 03/2019 - 05/2008
1	Retreatment 04/2015
1	Aftercare (After-Treatment) 04/2015
1	Subcutaneous Injections 02/2015
1	Phototherapy (Light Therapy) 10/2001